Dementia caused by Alzheimer's is one of the most common symptoms for patients suffering from neurodegenerative diseases. That is why a lot of research has been directed towards understanding the actual impact of the disease on the brain. While there are several studies being conducted, the use of Biomarkers is among those that are in advanced stages. Biomarkers help in understanding as well as monitoring the disease progression in a patient over time.

Today, Lance Ladic, Siemens Healthineers’ Director of Strategic Innovation is joined by three guests - Tammie Benzinger, Professor of Radiology at the Mallinckrodt Institute in St. Louis at Washington University, Dr. Anne Börjesson-Hanson, Director of Clinical Trials at the Department for Aging at Kalinsky University Hospital, and Duygu Tosun-Turgut, Associate Professor at the University of California San Francisco in the Department of Radiology and Biomedical Imaging. They’ll help us understand the progress that has been made so far in the study of Alzheimer’s disease.

Stay tuned to learn about the options that are currently available in the detection of Alzheimer's disease. You’ll also learn about the use of Biomarkers in monitoring the disease’s progression and how that information can be used in managing it. Lastly, you’ll hear about the ongoing Alzheimer's research and the questions they are seeking answers for.

What You’ll Learn in This Episode:

• The process of detecting the Alzheimer's disease (01:43)
• Why it is important to detect the disease early (04:17)
• The role that biomarkers can play in managing the disease (12:35)
• How smartphone and wearable devices are helping in studying the disease (16:32)
• What the future of monitoring this disease will look like (19:20)

Connect with Duygu Tosun:

• LinkedIn

Connect with Dr. Anne Börjesson-Hanson:

• LinkedIn

Connect with Tammie Benzinger:

• LinkedIn

Connect with Lance Ladic:

• LinkedIn

Hosted on Acast. See acast.com/privacy for more information.